Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Fear of GI symptoms has an important impact on quality of life in patients with moderate-to-severe IBS.

Lackner JM, Gudleski GD, Ma CX, Dewanwala A, Naliboff B; Representing the IBSOS Outcome Study Research Group.

Am J Gastroenterol. 2014 Nov;109(11):1815-23. doi: 10.1038/ajg.2014.241. Epub 2014 Sep 16.

2.

An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-D.

Lacy BE, Chey WD, Chang L.

Gastroenterol Hepatol (N Y). 2013 Nov;9(11 Suppl 5):1-24.

3.

The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis.

Rezaie A, Nikfar S, Abdollahi M.

Arch Med Sci. 2010 Mar 1;6(1):49-55. doi: 10.5114/aoms.2010.13507. Epub 2010 Mar 9.

4.

Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan.

Yakoob J, Abbas Z, Khan R, Hamid S, Awan S, Jafri W.

Saudi J Gastroenterol. 2011 Nov-Dec;17(6):371-5. doi: 10.4103/1319-3767.87176.

5.

Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?

Reddymasu SC, Sostarich S, McCallum RW.

BMC Gastroenterol. 2010 Feb 22;10:23. doi: 10.1186/1471-230X-10-23.

6.

A randomized controlled trial of imipramine in patients with irritable bowel syndrome.

Abdul-Baki H, El Hajj II, Elzahabi L, Azar C, Aoun E, Skoury A, Chaar H, Sharara AI.

World J Gastroenterol. 2009 Aug 7;15(29):3636-42.

7.

Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis.

Rahimi R, Nikfar S, Rezaie A, Abdollahi M.

World J Gastroenterol. 2009 Apr 7;15(13):1548-53.

8.

Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study.

Jarcho JM, Chang L, Berman M, Suyenobu B, Naliboff BD, Lieberman MD, Ameen VZ, Mandelkern MA, Mayer EA.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):344-52.

9.

Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.

Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, Quigley EM, Moayyedi P.

BMJ. 2008 Nov 13;337:a2313. doi: 10.1136/bmj.a2313. Review. Erratum in: BMJ.2009;338:b1881.

10.

Mind/Body psychological treatments for irritable bowel syndrome.

Naliboff BD, Fresé MP, Rapgay L.

Evid Based Complement Alternat Med. 2008 Mar;5(1):41-50. doi: 10.1093/ecam/nem046.

11.

IBS--review and what's new.

Foxx-Orenstein A.

MedGenMed. 2006 Jul 26;8(3):20. Review.

12.

Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations?

Noddin L, Callahan M, Lacy BE.

MedGenMed. 2005 Aug 29;7(3):17. Review. No abstract available.

Supplemental Content

Support Center